Sinepar
On the Bulgarian pack: Синепар 200 mg/50 mg таблетки с удължено освобождаване
200 mg/50 mg prolonged-release tablets · prolonged release tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Levodopa and decarboxylase inhibitors
- Made by
- Tchaikapharma High Quality Medicines AD
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Spain1 matching products
Canada3 matching products
Netherlands2 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Tchaikapharma High Quality Medicines AD · Bulgaria |
|---|---|
| Active substance | Levodopa and decarboxylase inhibitors |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 200 mg/50 mg prolonged-release tablets |
| Form | prolonged release tablet |
| Pack sizes | 100 |
| Classification | N04BA02 · Pain, sleep, mood, epilepsy and the brain |
| Name in the register | Синепар 200 mg/50 mg таблетки с удължено освобождаване |
| Reg. no. | 20090136 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Levodopa and decarboxylase inhibitors